Arialys

is a California-based biotechnology company that researches and develops novel therapies for the treatment of autoimmune neuropsychiatric diseases...
Read more
Arialys President & CEO: Peter Flynn

President & CEO

Peter Flynn

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$58M

Arialys Competitors

1Cabaletta Bio
2Dianthus
3Kyverna
4MiNK Therapeutics
5Moleculera Biosciences
6Novartis
7Allogene
8Legend Biotech
9Gilead
10Bristol-Myers Squibb

Trending Companies